Liminatus Pharma, Inc. Warrants
LIMNW
Last
$0.05
Day
+34.3%
1y
-54.9%
5y
-54.9%
52w
-89.4%
SPY YTD
+13.3%
Sec
—
Earnings
—
EMA 21
0.05
EMA 50
0.06
EMA 200
0.09
20d high
-26.5%
5y high
-89.4%
5y range
5th
Positions held
Your positionsLIMNW isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-13
Hold
avoid
Signal
Sell
Target
$0.08
Stop
$0.03
Stop distance
39.6%
Target vs last
+61.0%
Fundamentals
| Market cap | — | Enterprise value | — | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | 0.18 | Beta | 0.75 | Dividend yield | — |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | — | ROA | -95.7% | Debt / equity | 4.80 |
| Current ratio | 1.12 | Free cash flow | -$10.01M | Analyst recommendation | none | Mean target | — |
| 52w high | $0.05 | 52w low | $0.05 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | — | $0.0M |
| Op margin | — | — | — | — | — | — |
| Net income | -$1.4M | -$1.1M | -$8.2M | -$1.8M | — | -$0.3M |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$1.4M | -$1.1M | -$0.9M | -$0.7M | — | -$0.3M |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M |
| Op margin | — | — | — | — |
| Net income | -$10.2M | -$3.5M | -$5.0M | -$2.9M |
| Gross margin | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating income | -$3.0M | -$3.3M | -$4.8M | -$2.7M |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
Price (daily)
Full chart · RSI · MACD · patternsLIMNW · daily-14.8% over 12 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin